type-2-diabetes-mellitus

Documents about type-2-diabetes-mellitus

• Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia#238290ClinicalTrials.gov
• Long-term Efficacy and Safety of HMS5552 add-on to Metformin in T2DM Subjects#261478ClinicalTrials.gov
• DIABETES AWARENESS AND TREATMENT COMPLIANCE AMONG TYPE 2 DIABETIC PARENTS OF UDAYANA MEDICAL STUDENTS#15719DataCite
• DIABETES AWARENESS AND TREATMENT COMPLIANCE AMONG TYPE 2 DIABETIC PARENTS OF UDAYANA MEDICAL STUDENTS#15720DataCite
• Study To Understand Efficacy And Safety Of Investigational Agent (PF-04937319) Compared To Approved Agent (Glimepiride) In Patients With Diabetes On Metformin#160327ClinicalTrials.gov
• Effects of Sodium-glucose Co-transporter-2( SGLT-2 ) Inhibition on Sympathetic Nervous System Activity in Humans#234574ClinicalTrials.gov
• A Study of the Effect of Glucagon-like Peptide 1(GLP-1) Receptor Agonist in Combination With Metformin Therapy on Diabetes Remission in Subjects With Newly Diagnosed Type 2 Diabetes Who Are Overweight or Obese#160317ClinicalTrials.gov
• A Study to Assess 11 Beta-hydroxysteroid Dehydrogenase Type 1 Inhibition in Adipose Tissue by SPI-62#217174ClinicalTrials.gov
• Trial to Compare the Effects of Either Telmisartan (40-80 mg PO Once Daily) or Ramipril (5-10 mg PO Once Daily) on Renal Endothelial Dysfunction in Hypertensive Patients With Type 2 Diabetes#125983ClinicalTrials.gov
• A Research Study to Compare Two Types of Insulin, a New Insulin, Insulin Icodec and an Available Insulin, Insulin Glargine, in People With Type 2 Diabetes Who Have Not Used Insulin Before#127787ClinicalTrials.gov
• A Research Study to Compare Two Types of Insulin, a New Weekly Insulin, Insulin Icodec and an Available Daily Insulin, Insulin Degludec, in People With Type 2 Diabetes Who Use Daily Insulin#160258ClinicalTrials.gov
• Evaluating GLP-1 Receptor Agonist in the Treatment of Type 2 Diabetes: A Comparison of Medication Efficacy and Cost#183365BYU ScholarsArchive
• A Study of the Safety and Efficacy of Omarigliptin (MK-3102) in ≥18 and <45 Year-Old Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK-3102-028)#249560ClinicalTrials.gov
• Randomized, Double-blind (db), Placebo-controlled 18 Week Study of Linagliptin (BI 1356) in Type 2 Diabetic Patients With Insufficient Glycaemic Control on a Sulfonylurea Drug#261454ClinicalTrials.gov
• The HOME Trial: Hyperinsulinaemia: the Outcome of Its Metabolic Effects, a Randomized Controlled Trial#18541ClinicalTrials.gov
• Henagliflozin on Liver Fibrosis in Patients with MASLD and T2DM#121279ClinicalTrials.gov
• The CANTATA-D Trial (CANagliflozin Treatment and Trial Analysis - DPP-4 Inhibitor Comparator Trial)#123410ClinicalTrials.gov
• Antidiuretic Function Before and During Treatment With SGLT2 Inhibitors#143791ClinicalTrials.gov
• Human Immunodeficiency Virus (HIV) Food Insecurities#152613ClinicalTrials.gov
• The Effects of Metformin on Self-selected Exercise Intensity, Physical Fitness and Exercise-induced AMPK-activation#154866ClinicalTrials.gov
• GliflOzin in eLderly Diabetic patiENts: A praGmatic Intraclass Evaluation Trial#172513ClinicalTrials.gov
• Study of Efficacy and Safety of Vildagliptin as add-on Insulin Therapy in T2DM Patients#175090ClinicalTrials.gov
• Assessing the Effect of Met DR on Plasma Glucose and PK in Subjects With T2DM#208351ClinicalTrials.gov
• Endothelial Function as a Marker for Blood Pressure Control Among Hypertensive Diabetic Patients#245395ClinicalTrials.gov
• A Post Marketing Safety Study of Sitagliptin Phosphate/Metformin Hydrochloride (JANUMET®) (MK-0431A-235)#245446ClinicalTrials.gov
• Type 2 Diabetes Mellitus and Chronic Obstructive Pulmonary Disease – from Pathophysiology to Effective Management Overview.#269510NCBI PubMed Central
• A Bioequivalence Study of the Fixed Dose Combinations of Saxagliptin/Metformin XR Relative to Co-Administration#272326ClinicalTrials.gov
• PERsonalised Medicine for Intensification of Treatment (PERMIT) in type 2 diabetes mellitus: a target trial emulation from routine data#275148NCBI Bookshelf
• Evaluating the Efficacy and Safety of Empagliflozin Addition to Insulin and Oral Antidiabetic Medication (OAD) Regimen in Poorly Controlled Type 2 Diabetes and Obese Patient#143729ClinicalTrials.gov
• Phase 1b/2a Study of GSBR-1290 in Adult Overweight or Obese Healthy Subjects and Subjects With Type 2 Diabetes Mellitus#162397ClinicalTrials.gov
• Effects of Olive Oil and Bran Oil on Antioxidant Levels, Glycemic Control, and Lipid Profile in Patient Type 2 DM#245437ClinicalTrials.gov
• Treatment preference for once-weekly versus once-daily DPP-4 inhibitors in patients with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials#5184Europe PMC
• A Study to Assess the Addition of Sitagliptin to Metformin Compared With the Addition of Dapagliflozin to Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) and Mild Renal Impairment Who Have Inadequate Glycemic Control on Metformin With or Without a Sulfonylurea (MK-0431-838)#67823ClinicalTrials.gov
• Breaking the cycle: patient activation role in improving diabetes self-care adherence for alleviating diabetes distress.#9961PubMed
• Determinants of hypoglycemia and hospitalization among hemodialysis patients with type 2 diabetes: insights from a multicenter study in a resource-limited healthcare system#5091Europe PMC
• Study of the Effects of Vitamin C on Patients With Type 2 Diabetes#123667ClinicalTrials.gov
• Therapeutic Efficacy and Safety Evaluation of AI in the Management of Diabetes: A RCT Trial#141168ClinicalTrials.gov
• A Trial Investigating the Effect of 4 Weeks Dosing of XEN-D0501 on Blood Glucose Reduction in Patients With Diabetes#148707ClinicalTrials.gov
• Impact of the New Generation Anti-diabetic Drugs on Diabetic Retinopathy#234395ClinicalTrials.gov
• A Clinical Trial to Evaluate the Preference Regarding Convenience of Medication and Efficacy/Safety of SUGAMET®XR Tablet 5/1000mg#148714ClinicalTrials.gov
• Association between glycemic control, mental problems and nutrition in individuals with type 1 and type 2 diabetes mellitus in primary care settings.#219169NCBI PubMed Central
• Are Audiovisual Materials Superior to Printed Materials in Improving Awareness Among Type 2 Diabetic Patients?#146345ClinicalTrials.gov
• Dual task performance in adults with type 2 diabetes mellitus: A systematic review with meta-analysis.#154234NCBI PubMed Central
• Pharmacokinetics and Safety/Tolerability After Oral Administration of CKD-387 and D635 Under Fed Condition#154894ClinicalTrials.gov
• "Efficacy of Once Weekly GLP 1 Analogue: Semaglutide. A Multicenter Experience From Pakistan."#160273ClinicalTrials.gov
• Improving the Diabetic Health of Black Men: MANUP Feasibility Trial#184748ClinicalTrials.gov
• CMR in T2DM: The NSR Cohort#217162ClinicalTrials.gov
• Impact of cardiometabolic index on long-term mortality in young adults with type 2 diabetes mellitus.#219144NCBI PubMed Central
• The CANTATA-D2 Trial (CANagliflozin Treatment And Trial Analysis - DPP-4 Inhibitor Second Comparator Trial)#234389ClinicalTrials.gov
• Exploring insulin rejection through photo-elicitation among informal caregivers and patients with type 2 diabetes mellitus.#239986NCBI PubMed Central